Cargando…
Very-low-dose aspirin and surveillance colonoscopy is cost-effective in secondary prevention of colorectal cancer in individuals with advanced adenomas: network meta-analysis and cost-effectiveness analysis
BACKGROUND: Individuals with advanced colorectal adenomas (ACAs) are at high risk for colorectal cancer (CRC), and it is unclear which chemopreventive agent (CPA) is safe and cost-effective for secondary prevention. We aimed to determine, firstly, the most suitable CPA using network meta-analysis (N...
Autores principales: | Veettil, Sajesh K., Kew, Siang Tong, Lim, Kean Ghee, Phisalprapa, Pochamana, Kumar, Suresh, Lee, Yeong Yeh, Chaiyakunapruk, Nathorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981989/ https://www.ncbi.nlm.nih.gov/pubmed/33743605 http://dx.doi.org/10.1186/s12876-021-01715-7 |
Ejemplares similares
-
Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials
por: Veettil, Sajesh K., et al.
Publicado: (2017) -
Effects of calcium on the incidence of recurrent colorectal adenomas: A systematic review with meta-analysis and trial sequential analysis of randomized controlled trials
por: Veettil, Sajesh K., et al.
Publicado: (2017) -
Effects of chemopreventive agents on the incidence of recurrent colorectal adenomas: a systematic review with network meta-analysis of randomized controlled trials
por: Veettil, Sajesh K, et al.
Publicado: (2017) -
Efficacy and safety of celecoxib on the incidence of recurrent colorectal adenomas: a systematic review and meta-analysis
por: Veettil, Sajesh K, et al.
Publicado: (2019) -
Efficacy and safety of chemopreventive agents on colorectal cancer incidence and mortality: systematic review and network meta-analysis
por: Veettil, Sajesh K, et al.
Publicado: (2018)